INTRODUCTION AND OBJECTIVES: Tumor invasion of inferior vena cava (IVC) wall is considered to be a risk factor for recurrence and poor prognosis in renal cell carcinom. We use image-based preoperative prediction model to evaluate the probability of resection of IVC vascular wall because of tumor invasion.
METHODS: The clinical data of 88 patients with renal cell carcinoma with level I-IV tumor thrombus, who underwent radical nephrectomy and inferior vena cava thrombectomy between January 2014 and July 2018, was retrospectively analyzed. Parameters of multimodel image were measured in MRI/CT or ultrasound. Univariable and multivariable associations of clinical and radiographic features with IVC vascular wall resection were evaluated by logistic regression.
RESULTS: Postoperative pathology revealed a total of 41 patients (47.1%) developed vascular wall invasion. Coronal maximum IVC diameters in MRI or CT, color flow signal absence in ultrasound were significant risk factors by univariate and multivariate analysis. Multivariable Logistic regression analysis identified the following factors as independent risk factors for vascular wall invasion of inferior vena cava: the residual blood flow of the IVC (OR 0.152; P [ 0.002) and maximum coronal diameter of the IVC (OR 1.291; P < 0.001) .The final multivariable model developed to predict the need for IVC resection is summarized as follows: Ln{pre/(1-pre)} [0.256* maximum coronal diameter of the IVC -1.885* the residual blood flow of the IVC -7.602. The probability>50% indicated the IVC resection. 87.5% (77/88) patients predicted resection probability was consistent with the actual operation. 12.5% (11/88) cases was the opposite.
CONCLUSIONS: We present parameters of multimodel image associated resection of IVC vascular wall because of tumor invasion. This model could be used for preoperative planning to evaluate and predict the probability of partial resection or segmental resection of IVC.
INTRODUCTION AND OBJECTIVES: Micro RNAs (miRNA) are short non-coding RNA which are associated with posttranscriptional regulation of gene expression. As clear cell renal cell carcinoma (ccRCC) remains the most common primary renal malignancy and accounts for the majority of more than 14,000 deaths from renal malignancies each year, identification of miRNA signatures may portend prognostic significance could help subset patients with ccRCC eventually leading to therapeutic pathways. miRNAs have demonstrated importance in intratumor communication in ccRCC, however there are no established miRNA biomarkers. In this study, we sought to create a miRNA signature to predict risk overall mortality in patients with ccRCC.
METHODS: Patient's clinical data and level 3 miRNA expression profiles were obtained from the Cancer Genome Atlas (TCGA) repository. Clinical data was correlated with miRNA expression data. Regression analysis, Kaplan-Meier curves, and Heatmap clustering were performed using R packages ComplexHeatmap, Tidyverse, and Survival. Statistical analysis was performed using R Studio v3.4.4. Significant miRNAs were isolated and a diagnostic high, medium, and low score were created correlating to miRNA expression levels of each patient.
RESULTS: We identified 4 miRNAs (mir-204, mir-181a-1, mir29b-1, let-7d) that significantly affected survival and created a weighted score from these. (Score [ (0.776Âhsa-mir-204)þ(-0.507Â hsa-mir-181a-1)þ(-0.459Âhsa-mir-29b-1)þ(-0.42Âhas-let-7d)) We were able to subset the cohort using hierarchical clustering into 3 survival categories: low, medium, and high. The low, medium, and high score groups had 278, 84, and 103 subjects respectively. Subjects with a medium and high miRNA score show a decreased significance, p < 0.05 and p < 0.00005 respectively (Figure 1 ). On multivariate analysis, medium and high score along with age, nodal status, metastatic deposit, and T3 or greater lesion were all independently associated with overall survival. CONCLUSIONS: We have created a novel miRNA signature to predict survival in ccRCC. Prospective validation of these markers is ongoing along with further determination of let-7d's role in aggressive tumor development. 
